Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review-Reference-Cited by-同舟云学术

Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review

Published:2024-07 Issue: Volume:125 Page:104-110
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Dima A^ORCID,Vonk MC^ORCID,Garaiman A,Kersten BE,Becvar R,Tomcik M,Hoffmann-Vold A-M,Castellvi I^ORCID,Jaime JL Tandaipan,Brzosko M,Milchert M^ORCID,Krasowska D,Michalska-Jakubus M,Airo P^ORCID,Matucci-Cerinic M,Bruni C^ORCID,Iudici M^ORCID,Distler JHW,Gheorghiu AM^ORCID,Poormoghim H^ORCID,Motta F^ORCID,De Santis M^ORCID,Parvu M,Distler O,Mihai C^ORCID

Funder

Ministry of Health of the Czech Republic

EULAR

Publisher

Elsevier BV

Reference40 articles.

1. Gastrointestinal manifestations of systemic sclerosis;Shreiner;J scleroderma Relat Disord,2016

2. Gastrointestinal manifestations of systemic sclerosis: an updated review;Luquez-Mindiola;World J Clin Cases,2021

3. Antinuclear antibodies in systemic sclerosis: an update;Stochmal;Clin Rev Allergy Immunol,2020

5. Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features;Mierau;Arthritis Res Ther,2011

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pitfalls in the detection of anti-Nucleolar Organizer Region 90 (NOR90) antibodies;European Journal of Internal Medicine;2024-09